This study investigates the well-being and health-related quality of life in cancer patients and survivors during the COVID-19 pandemic. Using questionnaires may help researchers gain an understanding of how experiences during the COVID-19 pandemic (e.g., exposure, risk factors, testing, isolation, seropositivity, hospitalization, loss of family or friends, loss of income), may impact multiple domains of health-related quality of life (physical, emotional and social well-being), and other areas such as COVID-19-specific psychological distress (e.g., fear, anxiety and depressive symptoms), and disruptions to health care, finances, and social interactions.
PRIMARY OBJECTIVES:
I. Assess experiences during the coronavirus disease 2019 (COVID-19) pandemic (e.g.,
exposure, risk factors, testing, isolation, seropositivity, hospitalization, loss of family
or friends); COVID-19-specific psychological distress (e.g., fear, anxiety and depressive
symptoms); health, financial and social disruptions; perceived benefits and social support;
and health-related quality of life (HRQoL) in a convenience sample of cancer patients and
survivors.
II. Evaluate the extent to which COVID-19 experiences are associated with COVID-19-specific
psychological distress, health, financial and social disruptions, perceived benefits and
social support, and HRQoL.
III. Evaluate the extent to which resiliency factors such as social support and perceived
benefits moderate the effects of COVID-19 experiences on COVID-19-specific psychological
distress and HRQoL.
OUTLINE:
Patients complete an online questionnaire over 10 minutes regarding the COVID-19 pandemic
including testing, risks of exposure, whether people they know have acquired COVID-19, as
well as questions on how the pandemic has impacted their quality of life.
Other: Quality-of-Life Assessment
Ancillary studies
Other Name: Quality of Life Assessment
Other: Questionnaire Administration
Complete questionnaire
Inclusion Criteria:
- MD Anderson active patient (visit within past 5 years)
- ICD-10 confirmed cancer diagnosis
- Documentation of being alive per the cancer registry
- Patients who have signed consent for one of the following protocols: PA14-0241 or
LAB03-0320
- Has an active email address and/or can be contacted via MyChart
- English or Spanish speaker
Exclusion Criteria:
- Non-active patient (i.e., no visit within past 5 years)
- Language other than English or Spanish
- Patients who have previously consented to the following protocols: 2012-0112,
2009-0976, 2005-0035, or PA15-0336, because they will be contacted through separate
IRB protocols to complete this same survey
M D Anderson Cancer Center
Houston, Texas, United States
Investigator: Lorenzo Cohen
lcohen@mdanderson.org
Investigator: Lorenzo Cohen
Lorenzo Cohen
(713) 745-4260
lcohen@mdanderson.org
Lorenzo Cohen, Principal Investigator
M.D. Anderson Cancer Center